Scenario.press - libera espressione Scenario.press - libera espressione
Rezultatele cautarii
Vedeti tot
  • Conecteaza-te
    Conecteaza-te
    Inscrie-te
    Căutare
    Night Mode

Căutare

Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni

  • News Feed
  • EXPLORE
  • Pagini
  • Grupuri
  • Events
  • Blogs
  • Marketplace
  • Funding
  • Offers
  • Jobs
  • Courses
  • Movies
  • Developers
  • Postari
  • Blogs
  • Utilizatori
  • Pagini
  • Grupuri
  • Events
  • marketresearchers a adăugat un sunet Alte
    2024-07-15 10:50:46 -
    Hemoglobinopathy Market Growth Factors & Trends, Key Player Strategy Analysis by Fact MR
    The global hemoglobinopathy market (Marché de l’hémoglobinopathie) is projected to reach a value of US$ 788.1 million by 2024 and is expected to grow at a compound annual growth rate (CAGR) of 8.3%, reaching approximately US$ 1,745.7 million by 2034. Hemoglobinopathies are prevalent in regions such as sub-Saharan Africa, the Mediterranean, the Middle East, and parts of...
    0 Commentarii 0 Distribuiri 6K Views
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • marketresearchers a adăugat un sunet Alte
    2024-05-08 20:59:26 -
    Hemoglobinopathy Market Major Players, Key Growth Trends And Forecast by Fact MR
    In 2024, the global hemoglobinopathy market (ヘモグロビン症市場) is estimated to be worth US$788.1 million, with a projected compound annual growth rate (CAGR) of 8.3% through 2034. By 2034, the market size is expected to exceed US$1,745.7 million. The rise of genetic testing has led to a significant shift in the hemoglobinopathy market towards personalized medication. Companies are leveraging this...
    0 Commentarii 0 Distribuiri 6K Views
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
© 2025 Scenario.press - libera espressione Romaian
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About us Terms & Conditions Confidențialitate Business Model Donations Contacteaza-ne Director